Search results
Author(s):
Bjoern Stinn
,
Juergen Fornaro
,
Dennis Hibbeln
,
et al
Added:
3 years ago
Computed tomography coronary angiography (CTCA) has entered the level of daily clinical practice in many institutions worldwide. All studies previously performed on the diagnostic accuracy of CTCA have shown a high negative predictive value, indicating a high ability of this method to exclude relevant coronary artery disease.1–3 However, CTCA is highly demanding not just of the technology, but…
View more
Author(s):
Thomas A Foley
,
Sunil V Mankad
,
Nandan S Anavekar
,
et al
Added:
12 years ago
Left ventricular ejection fraction (LVEF) is one of the most commonly reported measures of left ventricular (LV) systolic function. It is the ratio of blood ejected during systole (stroke volume) to blood in the ventricle at the end of diastole (end-diastolic volume). If the LV end-diastolic volume (EDV) and end-systolic volume (ESV) are known, LVEF can be determined using the following equation:…
View more
CMR and Myocarditis
Author(s):
Rocio Hinojar
,
Eike Nagel
,
Valentina O Puntmann
Added:
3 years ago
Article
Contemporary Techniques for TAVI in Complex Patients
Video Series
Author(s):
Todd Rudo
Added:
3 years ago
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice, with a prevalence that substantially increases with age. Both the loss of atrial mechanical function and a rapid, irregular ventricular response contribute to potentially significant symptoms, including palpitations, fatigue, chest discomfort, light headedness or syncope. Additionally, AF is associated with a…
View more
Author(s):
John G Coghlan
,
Denis Pellerin
Added:
3 years ago
Goals in Pulmonary Arterial Hypertension Treatment
Pulmonary arterial hypertension (PAH) arises from pathological thickening, obstruction and constriction of the pulmonary arterioles.1 This leads to progressive elevation of pulmonary pressures initially on exertion, then at rest.2 Symptoms present late, often only when the pressures can rise little further and the cardiac output (CO) falls due…
View more
Author(s):
John G Coghlan
,
Denis Pellerin
Added:
3 years ago
Goals in Pulmonary Arterial Hypertension Treatment
Pulmonary arterial hypertension (PAH) arises from pathological thickening, obstruction and constriction of the pulmonary arterioles.1 This leads to progressive elevation of pulmonary pressures initially on exertion, then at rest.2 Symptoms present late, often only when the pressures can rise little further and the cardiac output (CO) falls due…
View more
Author(s):
Dan Wichterle
Added:
3 years ago
Myocardial infarction (MI) is associated with acute risk of early malignant arrhythmias that can be easily treated during in-hospital intensive care by defibrillation, adjuvant antiarrhythmic therapy or even catheter ablation in resistant cases. Indeed, such management resulted in substantial improvement in MI survival rate. Despite the implementation of primary percutaneous coronary…
View more
Author(s):
Jose Luis Zamorano
Added:
3 years ago
2D echocardiography (2DE) is a common diagnostic and treatment planning tool in clinical cardiology, especially for the assessment of left ventricular (LV) volume and function. However, traditional 2DE is severely limited by its dependence on geometrical assumptions, which can lead to inaccuracies in volume quantification.1 Because 3D echocardiographic (3DE) imaging eliminates geometrical…
View more
Author(s):
Alda Huqi
,
Giacinta Guarini
,
Doralisa Morrone
,
et al
Added:
3 years ago
Myocardial revascularisation in patients with stable chronic angina is performed with the aim of reducing cardiovascular death, reducing myocardial infarction (MI) and relieving angina symptoms. However, contrary to expectations, modern therapy with percutaneous coronary intervention (PCI) has not had a significant impact on hard outcomes.1–5 Indeed, as also summarised in a recently published…
View more